AI assistant
Biocon Ltd. — Capital/Financing Update 2023
Dec 13, 2023
61176_rns_2023-12-13_ca2b27ff-19cf-4c15-92b5-bf61e51f906f.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [132 x 52] intentionally omitted <==
Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423
CIN : L24234KA1978PLC003417
www.biocon.com
BIO/SECL/AJ/2023-24/132
December 13, 2023
| BIO/SECL/AJ/2023-24/132 December 13, 2023 |
www.biocon.com |
|---|---|
| To, The Manager BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street,Mumbai – 400 001 |
To, The Manager National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050 |
| Scrip Code – 532523 | Scrip Symbol - BIOCON |
Subject: Intimation under Regulation 30 of SEBI Listing Regulations.
Dear Sir/Madam,
Pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we hereby inform you that Bicara Therapeutics Inc. (“Bicara”), an associate company of Biocon Limited, has on December 12, 2023, completed its US$165 Million Series C financing. The proceeds of the funding shall be used to support the continued advancement of Bicara’s lead product candidate, BCA101, a first-in-class bifunctional EGFR/TGF-β inhibitor that is currently in clinical development for multiple cancer types. The media release made by Bicara in this regard can be accessed at https://www.bicara.com/bicara-therapeutics-announcesoversubscribed-165-million-series-c-financing/.
Consequent to this infusion of Series C funding and post allotment of shares by Bicara, the Company’s shareholding in Bicara on fully diluted basis will fall below 20% and thereby, Bicara will cease to be an associate company of Biocon Limited.
The above information will also be available on the website of the Company at www.biocon.com.
Kindly take the same on record and acknowledge.
Thanking You,
Yours faithfully,
For Biocon Limited
MAYANK Digitally signed by MAYANK VERMA VERMA Date: 2023.12.13 16:44:24 +05'30' _______
Mayank Verma
Company Secretary and Compliance Officer Membership No.: ACS 18776